Replies to post #346164 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Agree. Since the Rett endpoints are the classic accepted ones that are shared with the Trofinetide trial, showing stat sig and clinical superiority in those two endpoints is what will settle the outcome.